Upsher-Smith Laboratories to Market Vagifem® 10 mcg in Exclusive Agreement With Novo Nordisk Inc.
Upsher-Smith Adds ITI-111 (Nasal Midazolam) to CNS Pipeline
Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255
Upsher-Smith Laboratories Signs Agreement to Sublicense Tonabersat
Careers
|
Contact Upsher-Smith
|
Search
|
Privacy policy
|
Legal notices
UPSHER-SMITH LABORATORIES, INC., 6701 Evenstad Drive, Maple Grove, MN 55369, 1-800-654-2299
© 2001-2009 UPSHER-SMITH LABORATORIES, INC. All rights reserved.
